Involvement of Archaea in Carious Disease
CARIARCHAE
1 other identifier
interventional
200
1 country
1
Brief Summary
Dental caries is a major public health probleme the result of hard tissue demineralization and oral microbiota changes. Methanogenic archaea, mainly Methanobrevibacter oralis, are associated with various oral problems, including pathologies periodontal. Previous research has not really studied the Archaea in carious lesions, hence the importance of our study. Our study aims to explore their potential role in the the development of caries by analysing their prevalence and their quantification in relation to the carious risk individual. The aim is to improve understanding of the Cavity microbiology to advance management of this pathology in terms of prevention or of treatment. Our team is particularly competent in the field of Archaea, especially in the cultivation of Archaea methanogens since we have a dedicated platform. We also discovered the first human Nanoarchaea, opening up a whole new possible search field.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 16, 2025
CompletedFirst Posted
Study publicly available on registry
January 22, 2025
CompletedStudy Start
First participant enrolled
February 19, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 19, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2028
February 23, 2026
February 1, 2026
1 year
January 16, 2025
February 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Presence/absence of Archaea in participants' saliva samples.
36 months
Secondary Outcomes (2)
Quantity of Archaea in the salivary sample of the participants.
36 months
Viability/non-viability of Archaea in carious lesions
36 months
Study Arms (2)
low risk of carriages
EXPERIMENTALhigh risk for caries.
OTHERInterventions
Eligibility Criteria
You may qualify if:
- Male or female of legal age.
- Patient who is a beneficiary or entitled beneficiary of a social security
- Patient under the care of the Restorative and Preventive Dentistry of the PROMOD - Timone Dentistry Unit.
- Patients capable of giving written consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Asssistance Publique Hopitaux de Marseille
Marseille, 13354, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
jean-olivier ARNAUD GENERAL DIRECTOR
Assistance Publique Hopitaux De Marseille
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 16, 2025
First Posted
January 22, 2025
Study Start
February 19, 2026
Primary Completion (Estimated)
February 19, 2027
Study Completion (Estimated)
February 1, 2028
Last Updated
February 23, 2026
Record last verified: 2026-02